The Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for phosphodiesterase 5 (PDE-5) inhibitors regarding a new contraindication with guanylate cyclase ...
PHILADELPHIA -- Current anticoagulant or antiplatelet use is not necessarily a contraindication for administering tissue plasminogen activator (tPA) to a stroke patient in the emergency department, a ...
Bracco Diagnostics announced that the Food and Drug Administration (FDA) has lifted the contraindication for use of Lumason (sulfur hexafluoride lipid-type A microspheres) in patients with known or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback